Related Experiment Videos
Clinical implications of peripapillary atrophy in glaucoma.
1Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany. Jost.Jonas@ma.augen.uni-heidelberg.de
Current Opinion in Ophthalmology
|March 4, 2005
Summary
Peripapillary atrophy is a useful, though secondary, indicator for diagnosing glaucoma and differentiating its subtypes. It helps distinguish glaucomatous from non-glaucomatous optic nerve damage.
Area of Science:
- Ophthalmology
- Optometry
- Glaucoma Research
Background:
- Peripapillary atrophy (PPA) is a morphologic feature observed around the optic disc.
- Its role in diagnosing and monitoring glaucoma has been a subject of ongoing research.
Purpose of the Study:
- To evaluate the significance of peripapillary atrophy in diagnosing glaucomatous optic neuropathy.
- To assess its utility in differentiating various types of chronic open-angle glaucoma.
- To determine its value in distinguishing glaucomatous from non-glaucomatous eyes and detecting glaucoma progression.
Main Methods:
- Review of recent studies on peripapillary atrophy and glaucoma.
- Analysis of optic disc parameters, including PPA zones (alpha and beta) and neuroretinal rim.
- Comparison of PPA in glaucomatous versus non-glaucomatous optic nerve atrophy.
Main Results:
- Peripapillary atrophy is associated with glaucoma and glaucomatous disc hemorrhages, independent of neuroretinal rim area.
- Increasing PPA correlates with progressive glaucoma.
- PPA is a less sensitive parameter than neuroretinal rim for detecting glaucomatous damage but useful for differentiating chronic open-angle glaucoma subtypes.
- Pseudoexfoliation syndrome without glaucoma and arteritic anterior ischemic optic neuropathy do not enlarge PPA.
Conclusions:
- Peripapillary chorioretinal atrophy is a valuable, albeit secondary, morphologic variable in detecting glaucomatous abnormalities.
- It aids in differentiating chronic open-angle glaucoma types and distinguishing glaucomatous from non-glaucomatous optic nerve atrophy.